Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for PXMBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 7.366M
March 31, 2026 6.988M
December 31, 2025 8.022M
September 30, 2025 6.368M
June 30, 2025 7.679M
March 31, 2025 4.504M
December 31, 2024 5.723M
September 30, 2024 5.628M
June 30, 2024 4.201M
March 31, 2024 4.470M
December 31, 2023 4.416M
September 30, 2023 5.293M
June 30, 2023 5.391M
March 31, 2023 5.520M
December 31, 2022 5.736M
September 30, 2022 4.748M
June 30, 2022 4.550M
March 31, 2022 4.512M
December 31, 2021 4.483M
Date Value
September 30, 2021 6.746M
June 30, 2021 6.975M
March 31, 2021 6.314M
December 31, 2020 8.051M
September 30, 2020 7.465M
June 30, 2020 6.624M
March 31, 2020 6.414M
December 31, 2019 6.048M
September 30, 2019 4.886M
June 30, 2019 4.884M
March 31, 2019 4.045M
December 31, 2018 3.423M
September 30, 2018 2.387M
June 30, 2018 1.703M
March 31, 2018 1.509M
December 31, 2017 1.568M
September 30, 2017 1.452M
June 30, 2017 1.222M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Getinge AB 2.725B
Xvivo Perfusion AB 33.75M
Abbott Laboratories 57.45B
AngioDynamics, Inc. 96.34M
Alphatec Holdings, Inc. 779.49M

Total Liabilities (Quarterly) Related Metrics